However, the present finding of significant associations between genetically determined higher plasma SAP values and increased risk of AD and LBD is more specifically consistent with the association between neocortex SAP content and cognitive status at death that was recently observed in the Cognitive Function and Ageing Study [18]. This evidence concerns the gene APCS and Alzheimer disease.